Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53 - PubMed (original) (raw)
. 1993 May 20;363(6426):281-3.
doi: 10.1038/363281a0.
Affiliations
- PMID: 8387645
- DOI: 10.1038/363281a0
Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53
D H Mack et al. Nature. 1993.
Abstract
The p53 protein is apparently central to the development of human cancers because both alleles are often found to be mutated in different tumour types. In addition, wild-type p53 can inhibit transformation by viral and cellular oncogenes in vitro, so p53 has been classified as a tumour suppressor. Investigations of the normal function of p53 have indicated that at least one of its functions could involve the activation of gene expression through the binding of specific DNA-regulatory sequences. Also, overexpression of p53 can mediate growth arrest and repress transcription from a variety of promoters. We demonstrate here both in vivo and in vitro that expression of wild-type p53 specifically represses the activity of promoters whose initiation is dependent on the presence of a TATA box. Promoters whose accurate transcription is directed by a pyrimidine-rich initiator element, however, are immune to the effects of p53. Furthermore, we observe that repression is mediated by an interaction of p53 with basal transcription factor(s). Thus, p53 appears to repress the activity of certain promoters through direct communication with TATA box-dependent basal transcription machinery.
Similar articles
- p53 represses SV40 transcription by preventing formation of transcription complexes.
Perrem K, Rayner J, Voss T, Sturzbecher H, Jackson P, Braithwaite A. Perrem K, et al. Oncogene. 1995 Oct 5;11(7):1299-307. Oncogene. 1995. PMID: 7478550 - TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53.
Iotsova V, Crépieux P, Montpellier C, Laudet V, Stehelin D. Iotsova V, et al. Oncogene. 1996 Dec 5;13(11):2331-7. Oncogene. 1996. PMID: 8957074 - Posttranslational regulation of p53 tumor suppressor protein function.
Maxwell SA, Roth JA. Maxwell SA, et al. Crit Rev Oncog. 1994;5(1):23-57. doi: 10.1615/critrevoncog.v5.i1.20. Crit Rev Oncog. 1994. PMID: 7948107 Review.
Cited by
- CREB/ATF-dependent repression of cyclin a by human T-cell leukemia virus type 1 Tax protein.
Kibler KV, Jeang KT. Kibler KV, et al. J Virol. 2001 Mar;75(5):2161-73. doi: 10.1128/JVI.75.5.2161-2173.2001. J Virol. 2001. PMID: 11160720 Free PMC article. - The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.
Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L. Venot C, et al. EMBO J. 1998 Aug 17;17(16):4668-79. doi: 10.1093/emboj/17.16.4668. EMBO J. 1998. PMID: 9707426 Free PMC article. - p53 and the CNS: tumors and developmental abnormalities.
Fulci G, Van Meir EG. Fulci G, et al. Mol Neurobiol. 1999 Feb;19(1):61-77. doi: 10.1007/BF02741378. Mol Neurobiol. 1999. PMID: 10321972 Review. - Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1.
Li CJ, Wang C, Friedman DJ, Pardee AB. Li CJ, et al. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5461-4. doi: 10.1073/pnas.92.12.5461. Proc Natl Acad Sci U S A. 1995. PMID: 7777531 Free PMC article. - p53 acts as a co-repressor to regulate keratin 14 expression during epidermal cell differentiation.
Cai BH, Hsu PC, Hsin IL, Chao CF, Lu MH, Lin HC, Chiou SH, Tao PL, Chen JY. Cai BH, et al. PLoS One. 2012;7(7):e41742. doi: 10.1371/journal.pone.0041742. Epub 2012 Jul 24. PLoS One. 2012. PMID: 22911849 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous